Hank, J A <br/><br/>
Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2.  [electronic resource] 

 -  Cancer research  Sep 1990 
 - 5234-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal<br/>Antibody-Dependent Cell Cytotoxicity<br/>Cell Line<br/>Immunoglobulin G<br/>Interleukin-2--therapeutic use<br/>Killer Cells, Lymphokine-Activated--immunology<br/>Neoplasms--drug therapy<br/>Neuroblastoma<br/>Recombinant Proteins--therapeutic use<br/>Reference Values